PET Study of the Nicotinic System in Epilepsy (NICOPET)
Primary Purpose
Epilepsy
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
MRI of the brain
PET scan [18F]F-A-85380
PET scan [18F]FDG
Sponsored by
About this trial
This is an interventional basic science trial for Epilepsy
Eligibility Criteria
Inclusion Criteria:
- males
- 18-60 years old
- non-smokers
Exclusion Criteria:
- smoking during the past twelve months
- contraindications to MRI
- brain lesions on MRI (including hippocampal atrophy)
- neurological disorder (other than epilepsy) or psychiatric disorder
- neoplasia or coronary disease
- blood test showing : creatinine clearance < 50 ml/min, or platelet < 100 G/l, or leucocytes < 3.8 G/l, or ALT or AST > 2 x upper standard, or gamma-GT > 3 x upper standard, or albumin < 35 g/l or > 48 g/l .
- patients only : nuclear imaging during the past twelve months
- healthy volunteers only : ionising radiation exam during the past five years
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Active Comparator
Experimental
Experimental
Experimental
Experimental
Arm Label
Control group
Non lesional diurnal partial epilepsy
Idiopathic generalized epilepsy
Nocturnal frontal lobe epilepsy
Epileptic patients with Vagus Nerve Stimulation (VNS)
Arm Description
Outcomes
Primary Outcome Measures
Comparison of the cerebral distribution of the neuronal nicotinic acetylcholine receptors (nAChR) in the 5 groups of individuals by means of voxelwise and regional 18F-FA binding potential measurements
Parametric 18F-FA and 18F-FDG binding potential measurements will be compared between the different groups of patients with epilepsy and the control group in order to find specific changes in the cerebral distribution of the nicotinic receptors in the different types of epilepsy, by using a voxel-wise (SPM) and a volume of interest (VOI) analysis.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03268369
Brief Title
PET Study of the Nicotinic System in Epilepsy
Acronym
NICOPET
Official Title
PET Study of the Nicotinic System in Epilepsy
Study Type
Interventional
2. Study Status
Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
February 2012 (Actual)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
November 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Fabienne PICARD
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Mutations in neuronal nicotinic acetylcholine receptors (nAChRs) have been identified in the autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Despite the demonstration of a gain of function of the mutated receptors, the precise mechanisms leading to this nocturnal epilepsy are still unknown. In 2006 the investigators studied the nAChR cerebral distribution in a group of patients with ADNFLE carrying a nAChR mutation, by a PET-scan using [18F]-F-A-85380, a ligand with a high affinity and specificity for alpha4beta2 nicotinic receptors. The study showed a different pattern of brain distribution of the radiotracer in the ADNFLE patients when compared to a group of control subjects, with a significant increase of nicotinic receptor density in the patients in mesencephalon and cerebellum (Picard et al., Brain 2006). Based on the known biochemical and cellular circuits in the brainstem, these results suggest that the nAChR density increase in mesencephalon is involved in the pathophysiology of ADNFLE through the role of brainstem ascending cholinergic systems in arousal. The follow-up step consists of extending this examination to other forms of epilepsy, in order to verify the specificity of the hyperfixation pattern for ADNFLE, and search for a potential involvement of nicotinic receptors in other forms of epilepsy. The investigators aim to study 5 groups of subjects: control subjects (Group 1, 20 subjects); patients with a non lesional partial epilepsy and a predominance of diurnal seizures (Group 2, 12 subjects); patients with an idiopathic generalized epilepsy (Group 3, 12 subjects); patients with nocturnal frontal lobe epilepsy (Group 4, 3 subjects) and epileptic patients with vagal nerve stimulation (Group 5, 1 subject). For each patient, a cerebral MRI, [18F]- fluorodeoxyglucose (FDG) PET/CT and [18F]-F-A-85380 PET/CT examinations are planned. The investigators will perform data analyses on volume of distribution (Vt) parametric images which will be based on the ratio of brain tissue to unchanged F-A-85380 plasma at equilibrium. Statistical parametric mapping (SPM2) will be used to further study the parametric PET images. This study is primarily dedicated to demonstrate that the pattern of hyperfixation that was obtained in ADNFLE patients is specific for this disorder and does not constitute a common pattern to various forms of epilepsy. The investigators will also search for a possible involvement of the nAChRs in other forms of epilepsy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epilepsy
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
48 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control group
Arm Type
Active Comparator
Arm Title
Non lesional diurnal partial epilepsy
Arm Type
Experimental
Arm Title
Idiopathic generalized epilepsy
Arm Type
Experimental
Arm Title
Nocturnal frontal lobe epilepsy
Arm Type
Experimental
Arm Title
Epileptic patients with Vagus Nerve Stimulation (VNS)
Arm Type
Experimental
Intervention Type
Radiation
Intervention Name(s)
MRI of the brain
Intervention Description
to eliminate a structural intra-cerebral lesion
Intervention Type
Radiation
Intervention Name(s)
PET scan [18F]F-A-85380
Intervention Description
exam performed after iv injection of 200 MBq [18F]F-A-85380
Intervention Type
Radiation
Intervention Name(s)
PET scan [18F]FDG
Intervention Description
exam performed after iv injection of 200 MBq [18F]FDG
Primary Outcome Measure Information:
Title
Comparison of the cerebral distribution of the neuronal nicotinic acetylcholine receptors (nAChR) in the 5 groups of individuals by means of voxelwise and regional 18F-FA binding potential measurements
Description
Parametric 18F-FA and 18F-FDG binding potential measurements will be compared between the different groups of patients with epilepsy and the control group in order to find specific changes in the cerebral distribution of the nicotinic receptors in the different types of epilepsy, by using a voxel-wise (SPM) and a volume of interest (VOI) analysis.
Time Frame
1 month
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
males
18-60 years old
non-smokers
Exclusion Criteria:
smoking during the past twelve months
contraindications to MRI
brain lesions on MRI (including hippocampal atrophy)
neurological disorder (other than epilepsy) or psychiatric disorder
neoplasia or coronary disease
blood test showing : creatinine clearance < 50 ml/min, or platelet < 100 G/l, or leucocytes < 3.8 G/l, or ALT or AST > 2 x upper standard, or gamma-GT > 3 x upper standard, or albumin < 35 g/l or > 48 g/l .
patients only : nuclear imaging during the past twelve months
healthy volunteers only : ionising radiation exam during the past five years
12. IPD Sharing Statement
Citations:
PubMed Identifier
16815873
Citation
Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006 Aug;129(Pt 8):2047-60. doi: 10.1093/brain/awl156. Epub 2006 Jun 30.
Results Reference
background
Learn more about this trial
PET Study of the Nicotinic System in Epilepsy
We'll reach out to this number within 24 hrs